Adults 18 to 50, any sex, with Dehydration. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Measurements Grouped by Level or ErrorPrimary· 90 minutes
Number of measurements obtained with Dehydration Monitor with errors greater/less than 20% (as compared to Shekel B-200-P)
Samsung Gear S2 : <20% errors in measurements
Group
Value
95% CI
Group 1
48
Group 2
48
Group 3
49
Group 4
50
Samsung Gear S2 : >20% errors in measurements
Group
Value
95% CI
Group 1
2
Group 2
2
Group 3
1
Group 4
0
Samsung Gear Fit2 : <20% errors in measurements
Group
Value
95% CI
Group 1
47
Group 2
48
Group 3
46
Group 4
49
Samsung Gear Fit2 : >20% errors in measurements
Group
Value
95% CI
Group 1
3
Group 2
2
Group 3
4
Group 4
1
Sponsor's own description
Monitoring of a person's physical status is a key point for maintaining of "healthy life". Wearable devices provide a unique possibility for real-time monitoring. This study aims to estimate the accuracy of Spectrophon Dehydration Body Monitor (DBM) incorporated in smartwatch Samsung Gear S2 and sport band Samsung Gear Fit2 by comparing data obtained by DBM with the total weight lost during exertion.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tirat Carmel Mental Health Center
Last refreshed: 31 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03229109.